128 related articles for article (PubMed ID: 18629780)
1. Expression of Mina53 and its significance in gastric carcinoma.
Zhang Q; Hu CM; Yuan YS; He CH; Zhao Q; Liu NZ
Int J Biol Markers; 2008; 23(2):83-8. PubMed ID: 18629780
[TBL] [Abstract][Full Text] [Related]
2. Expression and significance of Musashi-1 in gastric cancer and precancerous lesions.
Kuang RG; Kuang Y; Luo QF; Zhou CJ; Ji R; Wang JW
World J Gastroenterol; 2013 Oct; 19(39):6637-44. PubMed ID: 24151393
[TBL] [Abstract][Full Text] [Related]
3. Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma.
Xing J; Wang K; Liu PW; Miao Q; Chen XY
Oncol Rep; 2014 Feb; 31(2):634-40. PubMed ID: 24337011
[TBL] [Abstract][Full Text] [Related]
4. [Significance of expression of Myc-induced nuclear antigen 53 in hepatocellular carcinoma and its relationship with patient prognosis].
Ye DX; Zhou X; Yang Q; Hu XY; Li H; Xiang FG
Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):259-265. PubMed ID: 32306660
[No Abstract] [Full Text] [Related]
5. Potential effects of Mina53 on tumor growth in human pancreatic cancer.
Tan XP; Dong WG; Zhang Q; Yang ZR; Lei XF; Ai MH
Cell Biochem Biophys; 2014 Jul; 69(3):619-25. PubMed ID: 24522517
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma.
Kuratomi K; Yano H; Tsuneoka M; Sakamoto K; Kusukawa J; Kojiro M
Kurume Med J; 2006; 53(3-4):71-8. PubMed ID: 17317935
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance.
Tokuyasu N; Shomori K; Nishihara K; Kawaguchi H; Fujioka S; Yamaga K; Ikeguchi M; Ito H
Gastric Cancer; 2008; 11(1):37-46. PubMed ID: 18373176
[TBL] [Abstract][Full Text] [Related]
8. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
9. Expression of nitric oxide synthase in human gastric carcinoma and its relation to p53, PCNA.
Wang YZ; Cao YQ; Wu JN; Chen M; Cha XY
World J Gastroenterol; 2005 Jan; 11(1):46-50. PubMed ID: 15609395
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of KLF6 and its significance in gastric carcinoma.
Zhang Q; Tan XP; Yuan YS; Hu CM; He CH; Wang WZ; Li JC; Zhao Q; Liu NZ
Med Oncol; 2010 Dec; 27(4):1295-302. PubMed ID: 19967571
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of IGF-2, PCNA, MMP-7, and α-actin in gastric carcinoma with Lauren classification.
Kuang RG; Wu HX; Hao GX; Wang JW; Zhou CJ
Turk J Gastroenterol; 2013; 24(2):99-108. PubMed ID: 23934455
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological evaluation of biological behavior of submucosal invasive gastric carcinomas: relationship among lymph node metastasis, mucin phenotype and proliferative activity.
Nakamoto J; Torisu R; Aoki R; Kimura Y; Yasuda M; Shiota K; Yamamoto Y; Ito S
J Med Invest; 2007 Feb; 54(1-2):99-108. PubMed ID: 17380020
[TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.
Tan XP; Zhang Q; Dong WG; Lei XW; Yang ZR
Oncol Lett; 2012 May; 3(5):1037-1041. PubMed ID: 22783387
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 protein in gastric cancer: an immunohistochemical study with correlation to proliferative activity.
Ioachim E; Goussia A; Stefanou D; Agnantis NJ
Anticancer Res; 1997; 17(1A):513-7. PubMed ID: 9066704
[TBL] [Abstract][Full Text] [Related]
16. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
17. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
18. Proliferative markers in gastric carcinoma and organoid differentiation.
Fujimori Y; Akamatsu T; Ota H; Katsuyama T
Hum Pathol; 1995 Jul; 26(7):725-34. PubMed ID: 7628843
[TBL] [Abstract][Full Text] [Related]
19. CYR61 downregulation correlates with tumor progression by promoting MMP-7 expression in human gastric carcinoma.
Maeta N; Osaki M; Shomori K; Inaba A; Kidani K; Ikeguchi M; Ito H
Oncology; 2007; 73(1-2):118-26. PubMed ID: 18337624
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]